Skip to main content

Laia Yañez Bisbe

Institutions of which they are part

Postdoctoral researcher
Cardiovascular Diseases
Vall Hebron Institut de Recerca

Laia Yañez Bisbe

Institutions of which they are part

Postdoctoral researcher
Cardiovascular Diseases
Vall Hebron Institut de Recerca

Projects

Inhibición del intercanviador sodio/calcio mitocondrial, NCLX, como estrategia terapéutica para reducir el daño miocárdico por isquemia-reperfusión durante el infarto de miocardio

IP: Antonio Rodríguez Sinovas
Collaborators: Laia Yañez Bisbe, Elisabet Miro Casas, Marisol Ruiz Meana, Laura Rubio Unguetti, Gino Freddy Sena Ganse
Funding agency: Fundación Eugenio Rodríguez Pascual
Funding: 25000
Reference: FERP/2024/RODRIGUEZ
Duration: 15/01/2025 - 14/01/2027

Inhibición del intercanviador sodio/calcio mitocondrial, NCLX, como estrategia terapéutica para reducir el daño miocárdico por isquemia-reperfusión durante el infarto de miocardio.

IP: Antonio Rodríguez Sinovas
Collaborators: Laia Yañez Bisbe, Remedios Rios Barrera, Laura Rubio Unguetti, Gino Freddy Sena Ganse
Funding agency: Instituto de Salud Carlos III
Funding: 127500
Reference: PI23/00260
Duration: 01/01/2024 - 31/12/2027

MARCAJE RADIOACTIVO DE LOS CANALES TRPV4 COMO NUEVA HERRAMIENTA DE DIAGNÓSTICO DE LA FIBROSIS CARDÍACA

IP: Begoña Benito Villabriga
Collaborators: Ignacio Ferreira González, Nuria Rivas Gandara, Antonio Rodríguez Sinovas, Laia Yañez Bisbe, José Raul Herance Camacho, Marisol Ruiz Meana, Javier Inserte Igual
Funding agency: Sociedad Española de Cardiologia
Funding: 15000
Reference: SEC/FEC-INV-BAS 23/26
Duration: 01/01/2024 - 31/10/2024

Papel de los canales TRPV4 en la fibrosis ventricular derecha: identificación de nuevos mecanismos moleculares y desarrollo de nuevas técnicas de diagnóstico

IP: Begoña Benito Villabriga
Collaborators: Laia Yañez Bisbe, Berta Miranda Barrio, Gino Freddy Sena Ganse
Funding agency: Instituto de Salud Carlos III
Funding: 152500
Reference: PI23/01854
Duration: 01/01/2024 - 31/12/2026

Related news

The project’s 4th annual meeting was recently held as part of the Fortalece–Salud programme of the Carlos III Health Institute.

Women have a mortality rate of 21% during the 30 days following surgery, compared with 11% in men, a difference that remains after taking patients’ clinical characteristics into account.

The families of the professionals had the opportunity to visit the facilities and discover how we work at the institution.

Related professionals

Javier Esparcia Estrela

Javier Esparcia Estrela

Predoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Read more
Susana Nuria Ayala Cortes

Susana Nuria Ayala Cortes

Research assistant
Infectious Diseases
Read more
Alba Jané Dern

Alba Jané Dern

Gestió i Administració
Communication Unit
Communication Directorate
Read more
Guillem Sarró Cardelús

Guillem Sarró Cardelús

Gestió i Administració
Unidad de Proyectos Post-Award
Competitive Research Directorate
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.